Track the Parmax Pharma share price and the full management transaction log of the company, a listed issuer based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Market capitalisation: €467.5m. The latest transaction was filed on 19 August 2026 (Disposal). Among the most active insiders: ALKESH M GOPANI. Every trade is openly available.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€363,102
4 ops.
Sell Volume
Buys n/a€363,102 Sells
Fundamental score
Ranked 27,274 of 28,775 companies
16.1
score / 100
Value
19
Quality
14
FCF yld-6.6%
Earn yld-8.5%
EV/EBITDA·
ROE·
Gross mgn18%
Net mgn-34%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Parmax Pharma is a company specialized in the pharmaceutical sector, listed on the XBOM. It focuses on developing innovative solutions for the treatment of various diseases.